David Briggs

Adjunct Professor

Member of NICM Research Committee

Professor David Briggs was appointed an Adjunct Professor at NICM in 2006. He is a member of the Research Committee of David BriggsNICM, the International Advisory Board on Hong Kong Chinese Materia Medica Standards, and the WHO Expert Advisory Panel on Traditional Medicine. He is also a WHO Temporary Adviser for the development of monographs for herbal medicines.

Professor Briggs has previously worked in a regulatory environment, most recently as Head of the Office of Complementary Medicines in the Australian Therapeutic Goods Administration and was an inaugural member of the Standing Committee of the Western Pacific Regional Forum for the Harmonization of Herbal Medicines. Before taking up his position in the Office of Complementary Medicines, he was Professor and Head of the School of Nutrition and Public Health at Deakin University in Victoria. He has an MSc from the University of Melbourne and a PhD from The School of Pharmacy, University of London.

Areas of Research / Teaching Expertise

  • Quality, safety and regulation of complementary medicine, including traditional medicine
  • Development and implementation of complementary medicine policy 

Grants / Projects

  • Traditional medicine policy and strategic development
  • Quality standards for traditional Chinese medicines

Awards and Recognition

  • Member, World Health Organization, Expert Advisory Panel on Traditional Medicines 2007−.
  • Temporary Adviser, World Health Organization, traditional and herbal medicine.
  • Member, International Advisory Board on Hong Kong Chinese Materia Medica Standards 2002−
  • Member, Standing Committee, Western Pacific Regional Forum for the Harmonization of Herbal Medicines (FHH) 2002−09.
  • Member, Sub-committee on Quality Assurance and Information, Western Pacific Regional Forum for the Harmonization of Herbal Medicines 2002−09.
  • Representative of the Therapeutic Goods Administration, International Regulatory, Cooperation for Herbal Medicines (IRCH) 2006−2009.
  • Chair, Therapeutic Goods Administration/Industry Consultation Group, Australian Regulatory Guidelines for Complementary Medicines 2003-09.